Complications of Oral Exposure to Fentanyl Transdermal Delivery System Patches

Journal of Medical Toxicology

Volumn 6, Issue 4, 2010, Pages 443-447

  Prosser, Jane M ^a   Jones, Brent E ^b   Nelson, Lewis ^c  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK CITY POISON CONTROL CENTER   (United States)

Author keywords

Fentanyl; Opioid; Oral abuse; Transdermal fentanyl

Indexed keywords

FENTANYL; HYDROCODONE; NALOXONE; PARACETAMOL;

ACUTE LUNG INJURY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BRADYCARDIA; BREATHING RATE; CONTINUOUS INFUSION; CYANOSIS; DRUG ABUSE; DRUG FATALITY; DRUG INTOXICATION; DRUG MISUSE; DRUG RESPONSE; FEMALE; HUMAN; HYPOTENSION; HYPOXIA; LETHARGY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NASOTRACHEAL INTUBATION; OPIOID INTOXICATION; RESPIRATORY ARREST; RESPIRATORY FAILURE; SEIZURE; SIDE EFFECT; SUICIDE; SYMPTOM; TRANSDERMAL PATCH; UNCONSCIOUSNESS; VOMITING; WITHDRAWAL SYNDROME;

ADMINISTRATION, ORAL; ADULT; ANALGESICS, OPIOID; DATABASES, FACTUAL; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; POISONING; RESPIRATION, ARTIFICIAL; SUBSTANCE-RELATED DISORDERS; SUICIDE, ATTEMPTED; TRANSDERMAL PATCH; TREATMENT OUTCOME;

EID: 78650042996     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-010-0092-8     Document Type: Article

References (24)

1. Mather LE (1983) Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet 8: 422-446.
2. Moore TJ, Cohen MR, Furberg CD (2007) Serious adverse drug events reported to the food and drug administration, 1998-2005. Arch Intern Med 167: 1752-1758.
3. Nelson LS (2006) Opioids. In: Goldfrank's Toxicologic Emergencies. 8th (ed.) New York: McGraw-Hill, pp 540-613.
4. http://drugtopics. modernmedicine. com/Pharmacy+Facts+&+Figures. Last accessed 03/28/08.
5. Nelson LS, Schwaner R (2009) Transdermal fentanyl: pharmacology and toxicology. J Med Toxicol 5: 230-241.
6. Janssen Pharmaceutical. Duragesic®approved package insert. Titusville, NJ. Available from: http://www. duragesic. com/duragesic/shared/pi/duragesic. pdf. Last accessed 06/06/2009.
7. Anderson DT, Muto JJ (2000) Duragesic transdermal patch: postmortem tissue distribution of fentanyl in 25 cases. J Anal Toxicol 24: 627-634.
8. Coon TP, Miller M, Kaylor D, Jones-Spangle K (2005) Rectal Insertion of fentanyl patches: a new route of toxicity. Ann Emerg Med 45: 473.
9. Tharp AM, Winecker RE, Winston DC (2004) Fatal intravenous fentanyl abuse: four cases involving extraction of fentanyl from transdermal patches. Am J Forensic Med Pathol 25: 178-181.
10. Marquardt KA, Tharratt RS (1994) Inhalation abuse of fentanyl patch. Clin Toxicol 32: 75-78.
11. Streisand JB, Varvel JR, Stanski DR et al (1991) Absorption and bioavailability of oral transmucosal fentanyl citrate. Anesthesiology 75: 223-229.
12. Jentzen JM. Alternative drug-delivery systems are subject to abuse. In: Clinical and Forensic Toxicology News. http://www. aacc. org/publications/toxicology/Documents/9023f590e32540b29c02cf27a1320efedec03. pdf. Last accessed 09/01/2009.
13. Barrueto F Jr, Howland MA, Hoffman RS (2004) The fentanyl tea bag. Vet Human Toxicol 46: 30-31.
14. http://www. fda. gov/Drugs/DrugSafety/InformationbyDrugClass/ucm163647. htm. Last accessed 10/20/2009.
15. http://www. fda. gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm172039. htm. Last accessed 10/20/2009.
16. Varvel JR, Shafer SL, Hwang SS et al (1989) Absorbtion characteristics of transdermally administered fentanyl. Anesthesiology 70: 928-934.
17. Arroyo AM, Smith J, Kriger S, Mowry J (2009) In-vitro release of fentanyl from transdermal patches in gastric and intestinal fluid. Clin Toxicol 47: 706.
18. Hardwick WE, King WD, Palmisano PA (1997) Respiratory depression in a child unintentionally exposed to transdermal fentanyl patch. South Med J 90: 962-964.
19. Marquardt KA, Tharratt RS, Musallam NA (1995) Fentanyl remaining in a transdermal system following three days of continuous use. Ann Pharmacother 29: 969-971.
20. Woodall KL, Martin TL, McLellan BA (2008) Oral abuse of fentanyl patches (Duragesic): seven case reports. J Forensic Sci 53: 222-225.
21. Kuhlman JJ, McCaulley R, Valouch TJ, Behonick GS (2003) Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases. J Anal Toxicol 27: 499-504.
22. Kramer C, Tawney M (1998) A fatal overdose of transdermally administered fentanyl. J Am Osteo Assoc 98: 385.
23. Grond S, Radbruch L, Lehmann KA (2000) Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin Pharmacokinet 38: 59-89.
24. Howland MA (2006) Antidotes in depth: naloxone. In Goldfrank's Toxicologic Emergencies 8th (ed.) New York: McGraw-Hill. pp 540-613.